Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Torrado

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
International Journal of Pharmaceutics|July 29, 2024
Leveraging 3D-printed microfluidic micromixers for the continuous manufacture of melatonin loaded SNEDDS with enhanced antioxidant activity and skin permeabilityBaris Ongoren, Aytug Kara, Luca Casettari, et al.
International Journal of Pharmaceutics|February 27, 2013
Hemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulationsDolores R Serrano, Leticia Hernández, Laura Fleire, et al.
Medical Mycology|June 3, 2017
Efficacy of a poly-aggregated formulation of amphotericin B in treating systemic sporotrichosis caused by Sporothrix brasiliensisKelly Ishida, Rafaela Alves Castro, Juan J Torrado, et al.
Antioxidants (Basel, Switzerland)|February 25, 2023
Melatonin as Modulator for Sulfur and Nitrogen Mustard-Induced Inflammation, Oxidative Stress and DNA Damage: Molecular TherapeuticsEva Ramos, Emilio Gil-Martín, Cristóbal De Los Ríos, et al.
Transplantation Proceedings|December 10, 2013
Associated characteristics and impact on survival of post renal-transplantation lymphoproliferative disease: case-control study from a regional registryM A Gentil Govantes, M Vidal Blandino, P Ruiz Esteban, et al.
Die Pharmazie|February 15, 2018
IVIVC approach based on carbamazepine bioequivalence studies combinationI González-García, V Mangas-Sanjuan, M Merino-Sanjuán, et al.
International Journal of Pharmaceutics|March 2, 2023
Targeting lung macrophages for fungal and parasitic pulmonary infections with innovative amphotericin B dry powder inhalersE de Pablo, P O'Connell, R Fernández-García, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 9, 2018
Pharmacokinetics and disposition of miltefosine in healthy mice and hamsters experimentally infected with Leishmania infantumM Dolores Jiménez-Antón, Estefanía García-Calvo, Cristina Gutiérrez, et al.
Molecular Pharmaceutics|January 7, 2015
Oral particle uptake and organ targeting drives the activity of amphotericin B nanoparticlesDolores R Serrano, Aikaterini Lalatsa, M Auxiliadora Dea-Ayuela, et al.
ACS Medicinal Chemistry Letters|April 19, 2019
SAR Studies and Biological Characterization of a Chromen-4-one Derivative as an Anti-<i>Trypanosoma brucei</i> AgentChiara Borsari, Nuno Santarem, Sara Macedo, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
International Journal of Pharmaceutics|July 29, 2024
Leveraging 3D-printed microfluidic micromixers for the continuous manufacture of melatonin loaded SNEDDS with enhanced antioxidant activity and skin permeabilityBaris Ongoren, Aytug Kara, Luca Casettari, et al.
International Journal of Pharmaceutics|February 27, 2013
Hemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulationsDolores R Serrano, Leticia Hernández, Laura Fleire, et al.
Medical Mycology|June 3, 2017
Efficacy of a poly-aggregated formulation of amphotericin B in treating systemic sporotrichosis caused by Sporothrix brasiliensisKelly Ishida, Rafaela Alves Castro, Juan J Torrado, et al.
Antioxidants (Basel, Switzerland)|February 25, 2023
Melatonin as Modulator for Sulfur and Nitrogen Mustard-Induced Inflammation, Oxidative Stress and DNA Damage: Molecular TherapeuticsEva Ramos, Emilio Gil-Martín, Cristóbal De Los Ríos, et al.
Transplantation Proceedings|December 10, 2013
Associated characteristics and impact on survival of post renal-transplantation lymphoproliferative disease: case-control study from a regional registryM A Gentil Govantes, M Vidal Blandino, P Ruiz Esteban, et al.
Die Pharmazie|February 15, 2018
IVIVC approach based on carbamazepine bioequivalence studies combinationI González-García, V Mangas-Sanjuan, M Merino-Sanjuán, et al.
International Journal of Pharmaceutics|March 2, 2023
Targeting lung macrophages for fungal and parasitic pulmonary infections with innovative amphotericin B dry powder inhalersE de Pablo, P O'Connell, R Fernández-García, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 9, 2018
Pharmacokinetics and disposition of miltefosine in healthy mice and hamsters experimentally infected with Leishmania infantumM Dolores Jiménez-Antón, Estefanía García-Calvo, Cristina Gutiérrez, et al.
Molecular Pharmaceutics|January 7, 2015
Oral particle uptake and organ targeting drives the activity of amphotericin B nanoparticlesDolores R Serrano, Aikaterini Lalatsa, M Auxiliadora Dea-Ayuela, et al.
ACS Medicinal Chemistry Letters|April 19, 2019
SAR Studies and Biological Characterization of a Chromen-4-one Derivative as an Anti-<i>Trypanosoma brucei</i> AgentChiara Borsari, Nuno Santarem, Sara Macedo, et al.
Pageof 13